Conditions: Multiple Myeloma
Keywords: Pomalidomide, CC-4047, Dexamethasone, Relapsed and refractory multiple myeloma, phase 2
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 36
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the efficacy and safety of pomalidomide in combination with dexamethasone in subjects with relapsed and refractory multiple myeloma.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Pomalidomide intervention 2: Dexamethasone
Intervention descriptions: intervention 1: 4 mg oral pomalidomide once daily Days 1-21 of each 28-day cycle intervention 2: 40 mg or 20 mg oral dexamethasone once daily on Days 1, 8, 15, 22 of each 28-day cycle

Protocol document: